AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...

Velo3D, Inc. and Linde Advanced Material Technologies Inc. have signed an agreement to supply domestically produced CuNi ...